Merck KGaA (OTCMKTS:MKGAF) Short Interest Up 27.9% in February

Merck KGaA (OTCMKTS:MKGAF) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 555,200 shares, a growth of 27.9% from the February 13th total of 434,000 shares. Based on an average daily trading volume, of 600 shares, the short-interest ratio is presently 925.3 days. Currently, 0.4% of the company’s shares are short sold.

Merck KGaA Trading Up 2.3 %

Merck KGaA stock traded up $3.40 during trading on Tuesday, hitting $150.50. The company had a trading volume of 370 shares, compared to its average volume of 780. Merck KGaA has a 1-year low of $135.00 and a 1-year high of $200.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company’s 50 day simple moving average is $146.49 and its 200-day simple moving average is $157.24. The stock has a market cap of $19.45 billion, a price-to-earnings ratio of 22.98 and a beta of 0.96.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.